Viridian Therapeutics, Inc. (VRDN)
30.87
+0.39
(+1.28%)
USD |
NASDAQ |
Nov 13, 16:00
30.86
-0.01
(-0.03%)
After-Hours: 19:59
Viridian Therapeutics Price : 30.87 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 30.24 | 30.96 | 29.81 | 30.87 | 1.204M |
| Nov 12, 2026 | 31.22 | 31.30 | 30.31 | 30.48 | 1.951M |
| Nov 11, 2026 | 31.01 | 31.63 | 30.32 | 31.25 | 2.830M |
| Nov 10, 2026 | 30.03 | 31.00 | 29.25 | 30.86 | 2.714M |
| Nov 09, 2026 | 29.28 | 30.38 | 28.60 | 30.19 | 3.907M |
| Nov 06, 2026 | 28.66 | 29.47 | 27.86 | 28.49 | 4.501M |
| Nov 05, 2026 | 29.58 | 29.61 | 28.48 | 28.55 | 3.438M |
| Nov 04, 2026 | 28.26 | 29.74 | 25.07 | 29.06 | 11.18M |
| Nov 03, 2026 | 25.60 | 26.21 | 24.52 | 25.15 | 4.063M |
| Nov 02, 2026 | 24.45 | 25.58 | 23.97 | 25.30 | 3.391M |
| Oct 30, 2026 | 24.77 | 25.00 | 24.14 | 24.67 | 1.711M |
| Oct 29, 2026 | 24.35 | 25.32 | 24.23 | 24.80 | 1.907M |
| Oct 28, 2026 | 23.72 | 24.42 | 23.66 | 24.27 | 1.413M |
| Oct 27, 2026 | 23.29 | 24.12 | 23.19 | 24.09 | 2.809M |
| Oct 26, 2026 | 22.50 | 23.35 | 22.33 | 23.34 | 1.515M |
| Oct 23, 2026 | 22.75 | 22.75 | 21.92 | 22.37 | 1.179M |
| Oct 22, 2026 | 23.00 | 23.59 | 22.66 | 22.82 | 1.546M |
| Oct 21, 2026 | 22.50 | 23.29 | 22.46 | 23.01 | 1.921M |
| Oct 20, 2026 | 21.10 | 22.68 | 20.85 | 22.43 | 1.975M |
| Oct 19, 2026 | 19.23 | 20.88 | 19.07 | 20.80 | 2.576M |
| Oct 16, 2026 | 19.67 | 19.78 | 18.94 | 19.03 | 2.457M |
| Oct 15, 2026 | 18.69 | 19.78 | 18.54 | 19.56 | 2.168M |
| Oct 14, 2026 | 18.19 | 18.74 | 18.01 | 18.38 | 3.734M |
| Oct 13, 2026 | 18.04 | 18.33 | 17.96 | 18.22 | 2.124M |
| Oct 12, 2026 | 19.00 | 19.18 | 18.21 | 18.30 | 1.947M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Travere Therapeutics, Inc. | 50.65 |
| Arrowhead Pharmaceuticals, Inc. | 47.78 |
| Vertex Pharmaceuticals, Inc. | 538.60 |
| TG Therapeutics, Inc. | 64.51 |
| ACADIA Pharmaceuticals, Inc. | 18.75 |
Price Related Metrics
| PS Ratio | 122.58 |
| PEG Ratio | -0.4055 |
| Price to Book Value | 7.261 |
| Earnings Yield | -13.53% |
| Market Cap | 3.505B |
| PEGY Ratio | -0.4055 |